January 12, 2023 | Biopharma, Crowd Funded Cures, Impetus Digital, Natalie Yeadon, Savva Kerdemelidis, diagnostics, off patent drugs, off-patent medicine, pharmacoeconomics, social enterprise, therapies
Savva Kerdemelidis, Founder & CEO of Crowd Funded Cures, explores the concepts of interventional pharmacoeconomics and pay-for-success contracts to fund new uses for off-patent drugs and other unmonopolizable therapies.
This content was provided by Impetus Digital
Company Details
